Carmen Brenner

Director, Manufacturing Sciences and Technologies (MSaT) • Novadip

Carmen is currently director of Manufacturing, Science and Technology (MSaT) at Novadip, a Belgium-based pharmaceutical company developing a unique platform for tissue regeneration in the field of bone and skin.

Carmen is working in the field of cell therapy for more than 10years. Prior joining Novadip, Carmen was head of Quality in another cell therapy company where she was leading QA and QC activities and was participating in the launching of Phase IIb and Phase III clinical trials in several European and non-European countries.

Carmen holds a PhD in Biomedical Sciences (Cancer Epigenetics) from the University of Brussels (ULB).